Obsidian Therapeutics, Inc

OBX Healthcare Biotechnology

14.02 4.42 +46.04%
Market cap
$593.0M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Mar '26 Dec '25 Mar '25 Dec '24
ROIC
0.00% 0.00% — 0.00%
Return on Tangible Assets
0.00% 0.00% — 0.00%
Free Cash Flow per Share
0.00 — 0.00 —
Other line items
Cash ROIC
0.00% 0.00% — 0.00%
Average Days of Payables
0.00 0.00 — 0.00
Depreciation/Fixed assets
0.00 0.00 — 0.00
Revenue per Share
0.00 — 0.00 —
Operating CF per Share
0.00 — 0.00 —
Capex per Share
0.00 — 0.00 —

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026